Mirum Pharmaceuticals (($MIRM)) announced an update on their ongoing clinical study. Study Overview: Mirum Pharmaceuticals is conducting a Phase 2 ...
An international research team, led by Shinghua Ding at the University of Missouri, has identified a previously unknown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback